Noscendo GmbH

Noscendo GmbH

Noscendo GmbH

Noscendo offers nextgeneration pathogen identification via NextGenerationSequencing of cell free nucleic acids in patients plasma samples.
Follow us
Alexa global traffic share
Latest funding
Undisclosed amount
Venture capital (Series A) - 2020
Paua Ventures Earlybird Venture Capital High-Tech Gründerfonds +1
Team Size
1–10
Employees
Location
Headquarters
Venture capital (Series A)
FinSMEs

Noscendo Raises Series A Funding